138
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X

, , , , , , & show all
Pages 44-50 | Received 27 Jul 2012, Accepted 12 Sep 2012, Published online: 15 Oct 2012
 

Abstract

Objective: The role of adipokines in the development of cardiac syndrome X (CSX) remains unknown.

Methods: Fifty-nine CSX subjects were retrospectively enrolled from our catheterization databank. Another 54 subjects with valvular heart disease or arrhythmia served as controls. Adipokines were measured by ELISA tests.

Results: The CSX had lower circulating adiponectin but higher leptin and higher leptin/adiponectin ratio (×1000) (3.78 ± 4.96 vs. 2.14 ± 5.67, p < 0.001) than those of the controls. In a multivariate analysis, a higher leptin/adiponectin ratio was a predictor of CSX, while insulin-resistance index was not.

Conclusions: Adipokines may be implicated in the pathogenesis of CSX.

Acknowledgments

The authors would like to thank the Biostatistics Taskforce of Taichung Veterans General Hospital for statistical support.

Declaration of interest

This study was supported in part by grants from the Yen Tjing Ling Medical foundation, Taiwan (CI-99- 13), Taichung Veterans General Hospital, Taiwan (TCVGH-1003101B, 1007307C, TCVGH-NCHU997610, TCVGH-HK1008001) and the National Science Council, Taiwan (NSC-99-2311-B-075A-001). The authors declare no conflict of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.